SecBot SecBot
144 ·Filed Sep 22, 2026

KRSA

Korsana Biosciences, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed1mo ago SEC0001950047-26-009757
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The sale amount is trivial and likely for tax or administrative purposes. No actionable signal for traders.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
KRSA ▲ +0.74% at T+20d
NEUTRAL call +0.74% · α vs SPY +0.06% · entry $32.30 → $32.54
Next anchor: T+60d in 7w
Latest observation: T+22 -11.46% FF3 residual α
Entry = T+0 close
Sep 22, 2026
via day close
T+1d
+15.14%
call +15.14% · α +15.22%
$37.19
settled 5w ago
T+5d
-0.93%
call -0.93% · α -0.25%
$32.00
settled 29d ago
T+20d
+0.74%
call +0.74% · α +0.06%
$32.54
settled 8d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Director Errol B. Desouza filed a Form 144 notice of intent to sell 100 shares of Korsana Biosciences common stock, with an estimated aggregate market value of $3,499. The shares were acquired upon vesting of restricted stock between September 2024 and October 2024. The proposed sale is de minimis in size and represents a routine, small-scale disposition by a director.

Key Facts

  • Filer: Director Errol B. Desouza
  • Proposed sale: 100 shares of common stock
  • Estimated market value: $3,499
  • Shares acquired via restricted stock vesting (09/01/2024 – 10/01/2024)
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  • Filing date: September 22, 2026

Financial Impact

Proceeds of approximately $3,499 — negligible relative to company market cap and insider holdings.

dilution

Risk Factors

  • Form 144 is an intent to sell — the sale may not be executed.
  • No material risk to the company or stock price from this filing.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-009757
Document: 0001950047-26-009757-index.html0001950047-26-009757
Document: 0001950047-26-009757.txt0001950047-26-009757
8 reports for KRSA
Performance horizon
Filters
Rows
Reports for KRSA — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
144
NEUTRAL ★ 2/10
$31.31awaiting T+20—$30.07 (−3.96%)
Oct 15, 2026
12d ago
SC 13G/A
NEUTRAL ★ 2/10
$32.38awaiting T+20—$30.07 (−7.13%)
Oct 15, 2026
12d ago
DEF 14A
NEUTRAL ★ 5/10
$32.38awaiting T+20—$30.07 (−7.13%)
Sep 23, 2026
4w ago
144
NEUTRAL ★ 2/10
$37.19 $33.43▼ −10.11%▼ −9.69%$30.07 (−19.14%)
Sep 22, 2026
5w ago
144
NEUTRAL ★ 1/10
$32.30 $32.54▲ +0.74%▲ +0.06%$30.07 (−6.90%)
Sep 18, 2026
5w ago
SC 13G
NEUTRAL ★ 4/10
$33.21 $31.41▼ −5.42%▼ −4.51%$30.07 (−9.45%)
Sep 18, 2026
5w ago
144
NEUTRAL ★ 2/10
$33.21 $31.41▼ −5.42%▼ −4.51%$30.07 (−9.45%)
Sep 16, 2026
5w ago
SC 13G
NEUTRAL ★ 3/10
$31.23 $34.32▲ +9.89%▲ +7.83%$30.07 (−3.71%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 9h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 22, 2026